=EF=BB=BFReta vs. Cancer

February 24, 2026 | Read Online

Reta vs. Cancer

New study just released

= = =

We are still early in the research. Human data will be ess= ential before drawing firm conclusions.

<= tr>=

Happy Tuesday!

I recently came across a preclinical study presented at the Society for Immunotherapy of Cancer= that genuinely made me p= ause(click here to read it).

The researchers looked at retatrutide and tested it in a= mouse model of pancreatic cancer.

The results were striking to say the least. Tumor growth was reduced to= a degree comparable to that achieved with anti-PD1 immunotherapy.

In simple terms, a metabolic drug common= ly associated with obesity treatment performed similarly to a frontline immu= ne checkpoint cancer therapy in reducing tumor growth in this model.<= /p>

Interestingly, this study was not cent= ered on dramatic weight loss or appetite suppression. The dose used did not s= ignificantly affect body weight, yet tumor growth decreased meaningfully.

Retatrutide=E2=80=99s benefits go= far beyond cosmetic fat loss.

They are metabolic. They are immunologic. They may even profoundly reshape t= he body's internal terrain.

FYI= , BioLongevity Labs&nb= sp;is running a storewid= e sale where everything is 30% off. Use code HUNTERW to get an additional 15= % off.

The Study

The r= esearchers used obese mice with implanted pancreatic tumors.

Pancreatic cancer is one of the most aggressi= ve and difficult cancers to treat.

The mice were divided into groups. One group received no treatment. One= received anti-PD1 immunotherapy. One received low-dose retatrutide. Another= received both therapies together.

The retatrutide group experienced about a 3X reduction in tumor volume. T= he anti-PD1 group saw about a 5X reduction. The combination did not dramatic= ally outperform either therapy alone.

What stands out is that the low-dose retatrutide dose did not cause m= eaningful weight loss. However, it did improve blood glucose levels.<= /p>

This suggests that tumor suppression w= as not simply due to reduced body fat or calorie restriction.

Something about improving the body's metabol= ic environment altered tumor progression.

When you improve glucose control, insulin signaling, inflammatory t= one, and cellular energy handling, you influence the biology that drives dis= ease processes.

And cancer is d= eeply intertwined with metabolic dysfunction.

<= b>What This Could Mean for Humans

This was a mouse study, so we cannot definitively claim that retatrut= ide treats or prevents cancer in people based on this data alone.

We can say that metabolism a= nd cancer are closely linked.

= Elevated insulin. Elevated glucose. Chronic inflammation. Visceral adiposity= . Impaired immune surveillance. These factors create conditions that favor t= umor growth.

If a compound impro= ves glucose control, lowers inflammatory tone, enhances insulin sensitivity,= and potentially influences immune function, it is reasonable to consider th= at it could support a less cancer-friendly internal environment.

<= /td>

= Rather than viewing this through the lens o= f direct cancer therapy, it makes sense to consider the overall environment w= ithin the body.

Retatrutide im= proves insulin sensitivity and reduces hyperglycemia. That shift may reduce t= he availability of fuel and the growth signals that tumors rely on.

Even at lower doses, these metabolic ch= anges may be meaningful.

Non-Cancer-Favoring= Terrain

Cancer develops wit= hin biological terrain.

A body with high fasting glucose<= /span>
A body with elevated insulin
A body with= systemic inflammation
A body with immune dysfunction

These conditions cr= eate fertile ground for pathological growth.

Retatrutide appears to influence multiple pathways simultaneou= sly.

It improves glucose regul= ation, flattens insulin spikes, reduces metabolic stress, and may modulate i= mmune signaling.

When glucose e= xcursions are stabilized, glycation stress declines.

When insulin sensitivity improves, excessive anabolic= growth signaling is reduced.

= When inflammatory tone decreases, immune surveillance may function more effi= ciently.

This intersection of m= etabolism and immunity is often referred to as immunometabolism. Longevity i= s shaped by the environment in which cells operate.

When that environment is stable, low inflammatory, insul= in sensitive, and energetically efficient, it becomes less supportive of pat= hological processes.

<= /tbody>

The Microdose Longevity= Perspective

Most people as= sociate retatrutide with aggressive fat loss protocols involving higher week= ly doses and significant appetite suppression.

There is another way to look at this.

Instead of focusing solely on weight loss, we can foc= us on metabolic optimization.

= A microdose under 2 mg per week may not produce dramatic appetite suppressio= n or rapid fat reduction.

Howev= er, based on what we understand about its mechanisms, it could still improve= glucose handling and metabolic stability.

Longevity is built on reducing chronic metabolic stress over the= course of decades.

If a small w= eekly dose helps stabilize blood sugar, improve insulin sensitivity, and low= er systemic stress without excessive suppression of appetite or energy, that= becomes a sustainable strategy.

Consistency matters more than intensity. Subtle improvements maintained ov= er the years can compound in powerful ways.

Re= ta Beyond Fat Loss

For year= s, I have emphasized that GLP-1 agents are metabolic regulators rather than s= imple fat loss drugs.

Retatrut= ide extends that concept because of its triple receptor activity. By influen= cing GLP-1, GIP, and glucagon signaling, it reshapes energy handling at the s= ystems level.

The cancer model re= inforces the idea that improving metabolic health can broadly influence chro= nic disease pathways, including those involved in tumor biology.

<= /td>

= If low-dose retatrutide can meaningfully r= educe tumor progression in an aggressive cancer model without causing weight= loss, that suggests its metabolic influence runs deeper than body compositi= on changes alone.

That opens th= e door to considering this molecule within a broader longevity framework.

Final Thoughts

Even so, the data's direction is compelling.

Improving metabolic signaling alone influenced tumor= biology in this model. That reinforces the central role of insulin resistan= ce, hyperglycemia, and chronic inflammation in disease progression.

For those focused on long-term health, t= he goal extends beyond leanness.

The objective is metabolic resilience. Stable glucose. Controlled insulin= . Low inflammatory tone. Effective immune surveillance.

If a microdose of retatrutide under 2 mg per week c= an help support that environment without extreme appetite suppression or mus= cle loss, it becomes a strategic tool within a longevity framework.

Steady metabolic optimization over time= may prove more impactful at solving the cancer epidemic than we could ever h= ave imagined!

Best,

Hunter Williams

= <= tr>

Amazon Storefront

= <= /table>

Want more? Here=E2=80=99s how you can work with me:

=F0=9F=91=89Join my priv= ate coaching group, The AXION Collective:

<= ul style=3D"font-weight:normal;list-style-type:disc;margin-bottom:12px !impo= rtant;margin-top:12px !important;padding:0px 0px 0px 0px;">

The A= XION Collective

=F0=9F=91=89Try Zeroats, the world=E2= =80=99s first sugar-free, naturally flavored oatmeal:

St= ore: https://zeroats.com/<= span style=3D"font-size:1.5rem;">
Amazon: https://a.co/d/2gq1zJ9

=F0=9F=91=89Link To All My Old Videos:

<= /td>

DropBox= with all videos

=F0=9F=91=89Audio Versions of All Videos:

Itunes<= /p>
Spotify

=F0=9F=91=89= Get the Peptide Cheat Sheet:

=
Peptide Cheat Sheet

=F0=9F=91=89All my daily essentials on Amazon

=F0=9F=91=89Get discounts on your favorite peptides and resea= rch chemicals:

PEPTIDES
- BioLongevity Labs (use cod= e hunterw for 15% off): https://biolongevitylabs.com/

=F0=9F=91=8910% off the BEST workout sup= plements from Unmatched Supps (pre-workout, whey protein, creatine, EAAs, el= ectrolytes - use code HUNTERW at checkout):

https://www.unmatchedsupps.com?sca_r= ef=3D8677061.S6mh8SOsogBzjOO

=F0=9F=91=89Submit A Vid= eo Topic For My Next YouTube Video:

https://hun= terwilliamsvideotopic.carrd.co/

<= td align=3D"left" valign=3D"top" height=3D"2" style=3D"height:2px;"> Terms of Service

Update your email preferences or unsubscribe here

=C2=A9 2026 Hunter's Health Hacks

228 Park A= ve S, #29976, New York, New York 10003, United States

= --Apple-Mail-C546A0F2-5038-4F47-9F00-C6153BF2752D--